Meta Pixel

News and Announcements

Focus – Funding methods in the UK

  • Published December 20, 2022 5:12AM UTC
  • Publisher Callum Melrose
  • Categories Capital Raising Tips

There is no one answer to this question as to what the best start up funding method is in the UK as it is constantly changing and evolving.

However, some popular sources of start up funding for businesses in the UK include high net worth individuals, family offices, venture capitalists, private equity firms, and angel investors. Additionally, government programs such as the Seed Enterprise Investment Scheme (SEIS) and the Business Growth Fund (BGF) offer a range of funding opportunities for small businesses. Finally, many UK cities have their own initiatives designed to support start ups, such as the London Economic Development Corporation (LEDC).

Who you target depends on factors such the stage of your business, the current economic landscape and the timelines you are working on. It is often best practice to have conversations with a broad range of investors as you grow your investor network.

So, if you are looking for start up funding in the UK, it is important to do your research, leverage the support in your network and speak with experienced professionals to find the right source of funding for your business.

Would love to hear your experiences raising!

Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.

Your capital engagement platform

With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now